Chronic Kidney Disease (CKD)

Moderate Evidence

Chronic Kidney Disease (CKD)

Chronic Kidney Disease (CKD) is a long-term condition in which the kidneys gradually lose their ability to filter waste products, balance fluids and electrolytes, regulate blood pressure, and support red blood cell and bone metabolism. CKD is typically defined by abnormalities in kidney structure or function that persist for more than three months, often measured by a reduced estimated glomerular filtration rate (eGFR) and/or markers of kidney damage such as albumin in the urine. Because the kidneys influence many body systems, CKD is not only a kidney disorder but also a broader metabolic and cardiovascular condition.

CKD is a major global health issue. It is common among adults and becomes more prevalent with age, particularly in people with diabetes, hypertension, cardiovascular disease, obesity, autoimmune disease, or a family history of kidney disease. In many cases, CKD progresses silently over years, with few symptoms in early stages. As kidney function declines, people may experience fatigue, swelling, changes in urination, nausea, poor appetite, itching, muscle cramps, sleep disturbance, or difficulty concentrating, although these features are often nonspecific.

The significance of CKD lies in both its direct and indirect effects. Advanced disease can lead to kidney failure, requiring dialysis or kidney transplantation. Even before that stage, CKD is associated with increased risk of heart disease, stroke, anemia, mineral and bone disorders, electrolyte imbalance, and hospitalization. Current frameworks often classify CKD by both GFR category and albuminuria category, which helps estimate risk of progression and complications. This risk-based approach reflects the fact that two people with similar eGFR levels may have different long-term outlooks depending on the amount of protein leakage and other factors.

A balanced discussion of CKD also includes the lived experience of chronic illness. Many individuals manage multiple overlapping conditions, frequent laboratory monitoring, dietary changes, medication review, and uncertainty about progression. Conventional medicine focuses on identifying the cause, slowing progression, and reducing complications. Traditional and integrative systems often frame CKD in terms of constitutional weakness, impaired fluid metabolism, inflammation, or depletion of vital energy, emphasizing long-term support, whole-person assessment, and quality of life. Across perspectives, careful coordination with qualified healthcare professionals is important because kidney impairment changes how the body handles herbs, supplements, and medications.

Western Medicine Perspective

Western / Conventional Medicine Perspective

In conventional medicine, CKD is understood as the result of ongoing structural damage or functional decline in the kidneys. Common causes include diabetic kidney disease, hypertensive nephrosclerosis, glomerulonephritis, polycystic kidney disease, obstructive uropathy, recurrent kidney injury, and autoimmune or systemic disorders. Diagnosis relies on laboratory and clinical assessment, especially serum creatinine-based eGFR, urine albumin-to-creatinine ratio, urinalysis, blood pressure measurement, medication review, and sometimes kidney imaging or biopsy. Staging systems from organizations such as KDIGO combine GFR and albuminuria to stratify risk and guide monitoring.

Management in western medicine centers on slowing progression and reducing cardiovascular and metabolic complications. Research strongly supports attention to blood pressure control, diabetes management, reduction of albuminuria, smoking cessation, and review of potentially nephrotoxic exposures. Depending on the underlying condition and stage, clinicians may also address anemia, acidosis, bone-mineral abnormalities, fluid overload, and electrolyte disturbances such as high potassium. In advanced CKD, care planning may include education about kidney replacement therapy options, including dialysis and transplantation, as well as supportive or conservative kidney care.

The evidence base for CKD is substantial, but clinical care is complex because progression varies widely. Some people remain stable for years, while others decline more rapidly depending on cause, genetics, inflammation, cardiovascular burden, and access to care. Conventional medicine also recognizes the importance of nutrition, symptom burden, mental health, and social determinants of health. Consultation with nephrology and other healthcare professionals is commonly part of comprehensive management, especially when kidney function declines, albuminuria is significant, or the cause is uncertain.

Eastern & Traditional Perspective

Eastern / Traditional Medicine Perspective

In Traditional Chinese Medicine (TCM), chronic kidney disease is not identical to a single classical diagnosis but is often interpreted through patterns involving Kidney deficiency, Spleen weakness, dampness, phlegm, blood stasis, or impaired water metabolism. Depending on presentation, fatigue, edema, lower back weakness, nighttime urination, poor appetite, coldness, or heat signs may be viewed as different pattern expressions. Traditional approaches have historically aimed to tonify Kidney and Spleen function, move blood, transform dampness, and support fluid balance, using individualized herbal formulas, acupuncture, moxibustion, and dietary principles. In this framework, CKD is often seen as a chronic, layered disorder involving both deficiency and accumulation.

In Ayurveda, kidney dysfunction may be discussed in relation to imbalances in doshas, especially disturbances in Kapha and Vata, altered water metabolism, weakened digestive/metabolic function (agni), and accumulation of metabolic waste (ama). Traditional Ayurvedic interpretation may connect edema, fatigue, urinary changes, and systemic depletion with broader disturbances in tissue nourishment and elimination. Herbal preparations, food-based approaches, purification concepts, and daily routine practices have been traditionally used with the goal of restoring balance rather than targeting kidney biomarkers alone.

From an integrative and naturopathic perspective, CKD is often approached through whole-person assessment that may include inflammation, metabolic health, vascular health, dietary burden, oxidative stress, and quality of life. However, the eastern/traditional literature must be interpreted cautiously in CKD because reduced kidney function alters clearance of herbal compounds and minerals, and some traditional remedies have been associated with nephrotoxicity, adulteration, or heavy metal contamination. Research on selected herbal formulations and acupuncture is growing, but many studies are small, heterogeneous, or methodologically limited. For this reason, any traditional or integrative approach is generally discussed within the context of careful supervision and coordination with licensed healthcare professionals familiar with kidney disease.

Supplements & Products

Evidence & Sources

Moderate Evidence

Promising research with growing clinical support from multiple studies

  1. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
  2. National Kidney Foundation
  3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  4. The Lancet
  5. New England Journal of Medicine
  6. JAMA
  7. Cochrane Database of Systematic Reviews
  8. National Center for Complementary and Integrative Health (NCCIH)
  9. World Health Organization
  10. Kidney International

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.